Feedback / Questions
AVS100 - Avstera
https://www.prnewswire.com/news-releases/avstera-therapeutics-announces-fda-clearance-of-ind-application-for-avs100-a-novel-highly-selective-hdac6-inhibitor-targeting-solid-tumors-302017848.html
Dec 18, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next